Early targeted antibacterial therapy is essential when treating invasive group A streptococcal infection

Author：  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.28, Iss.12, 2012-12, pp. : 9-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antibacterial Therapy for Acute Group A Streptococcal Pharyngotonsillitis: Short-Course Versus Traditional 10-Day Oral Regimens

By Brook I.  

Pediatric Drugs, Vol. 4, Iss. 11, 2002-01 ,pp. : 747-754

Adis International

Access to resources Recommend Favorite

Invasive Group A Streptococcal Disease: Epidemiology, Pathogenesis and Management

By Steer Andrew C.   Lamagni Theresa  

Drugs, Vol. 72, Iss. 9, 2012-06 ,pp. : 1213-1227

Adis International

Access to resources Recommend Favorite

Prophylactic, empirical, pre-emptive and targeted antibacterial therapy all play a role in invasive aspergillosis

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 25, Iss. 1, 2009-01 ,pp. : 18-22

Adis International

Access to resources Recommend Favorite

Optimization of antifungal therapy is crucial when treating adults with invasive candidiasis in the intensive care unit

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 12, 2010-12 ,pp. : 15-18

Adis International

Access to resources Recommend Favorite

Adalimumab: Necrotising group A streptococcal periorbital infection: case report

By  

Reactions Weekly, Vol. 1, Iss. 1358, 2011-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite